Skip to Content
 

News: Breast Cancer Research Program

Balko lands Mary Kay Foundation grant for breast cancer research

Thursday, December 5th, 2019

Vanderbilt-Ingram Cancer Center’s Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.

Pietenpol, Wilson land Komen cancer research support

Thursday, October 24th, 2019

Two Vanderbilt-Ingram Cancer Center investigators have received financial support from Susan G. Komen for breast cancer research.

Study backs genetic testing for all metastatic breast cancer patients

Friday, September 6th, 2019

Testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies.

Grant strengthens breast cancer research efforts

Saturday, August 31st, 2019

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

Encephalitis identified as rare toxicity of immunotherapy treatment

Monday, July 22nd, 2019

Researchers are chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.

A critical factor for wound healing

Friday, July 19th, 2019

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing.

Research team documents potential new treatment path for breast cancer

Friday, January 18th, 2019

Immunotherapies that take off the “brakes” on the adaptive anti-tumor response have worked well in melanoma and lung cancer but less so in breast cancers. That could change.

Breast cancer-killing RIG

Friday, December 14th, 2018

A recent study in the journal Cancer Research demonstrates that a RIG-I agonist has potent immunogenic and therapeutic effects in breast cancer.

Clues to bone metastases

Monday, November 5th, 2018

A recent study by Rachelle Johnson, Ph.D., and colleagues looked at factors influencing the ability of breast cancer cells to colonize bone and enter and exit a dormant state.

Cancer Center investigators awarded Komen grants

Friday, October 12th, 2018

Vanderbilt-Ingram Cancer Center (VICC) investigators have received financial support from Susan G. Komen for breast cancer research.

Next Page »